Cargando…
Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021
IMPORTANCE: The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations. OBJECTIVE: To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak. DESIGN, SETTING, AND PARTICIPANTS: This case series was conducted in Chin...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856606/ https://www.ncbi.nlm.nih.gov/pubmed/36602797 http://dx.doi.org/10.1001/jamanetworkopen.2022.49710 |
_version_ | 1784873673854812160 |
---|---|
author | Yang, Hong Qi, Qi Zhang, Yong Wen, Ning Cao, Lei Liu, Yu Fan, Chunxiang Yan, Dongmei Zhu, Xiaoping Hao, Lixin Zhu, Shuangli Ma, Qianli Liu, Jiajie Ma, Chao Nan, Lei Chen, Yong Ma, Xiaozhen Chen, Na Deng, Kun Shao, Ge Ding, Xianxiang An, Zhijie Rodewald, Lance E. Li, Xiaolei Wang, Dongyan Zhu, Hui Wang, Huaqing Feng, Zijian Xu, Wenbo Zhou, Jiushun Yin, Zundong |
author_facet | Yang, Hong Qi, Qi Zhang, Yong Wen, Ning Cao, Lei Liu, Yu Fan, Chunxiang Yan, Dongmei Zhu, Xiaoping Hao, Lixin Zhu, Shuangli Ma, Qianli Liu, Jiajie Ma, Chao Nan, Lei Chen, Yong Ma, Xiaozhen Chen, Na Deng, Kun Shao, Ge Ding, Xianxiang An, Zhijie Rodewald, Lance E. Li, Xiaolei Wang, Dongyan Zhu, Hui Wang, Huaqing Feng, Zijian Xu, Wenbo Zhou, Jiushun Yin, Zundong |
author_sort | Yang, Hong |
collection | PubMed |
description | IMPORTANCE: The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations. OBJECTIVE: To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak. DESIGN, SETTING, AND PARTICIPANTS: This case series was conducted in China after a VDPV2 was detected in stool specimens from a child with acute flaccid paralysis (AFP) in Sichuan Province in 2019, 3 years after the global withdrawal of live, attenuated type 2 oral poliovirus vaccine (OPV). Investigation followed National Health Commission and World Health Organization guidance and included searching hospitals for unreported AFP cases; testing stool specimens from the child, his contacts, and local children; enhanced environmental surveillance for VDPV2s in wastewater; and measuring vaccination coverage. Sabin-strain IPV campaigns were conducted in a wide geographic area. MAIN OUTCOMES AND MEASURES: Any VDPV2 detection after completion of the supplementary immunization activities. RESULTS: A 28-nucleotide-change VDPV2 was isolated from a young boy. Three VDPV2s were detected in healthy children; 2 were contacts of the original child, and none had paralysis. A search of 31 million hospital records found 10 unreported AFP cases; none were polio. No type 2 polioviruses were found in wastewater. Prior to the event, polio vaccine coverage was 65% among children younger than 5 years. Sabin-strain IPV campaigns reached more than 97% of targeted children, administering 1.4 million doses. No transmission source was identified. More than 1 year of enhanced poliovirus environmental and AFP surveillance detected no additional VDPVs. CONCLUSIONS AND RELEVANCE: These findings suggest that the circulating VPDV2 outbreak in 2019 was associated with low vaccine coverage. An investigation discovered 3 infected but otherwise healthy children and no evidence of the virus in wastewater. Following Sabin-strain IPV–only campaigns expanding from county to prefecture, the poliovirus was not detected, and the outbreak response was considered by an expert panel and the World Health Organization to have been successful. This success suggests that the Sabin-strain IPV may be a useful tool for responding to circulating VDPV2 outbreaks when high-quality supplementary immunization activities can be conducted and carefully monitored in settings with good sanitation. |
format | Online Article Text |
id | pubmed-9856606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-98566062023-02-03 Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021 Yang, Hong Qi, Qi Zhang, Yong Wen, Ning Cao, Lei Liu, Yu Fan, Chunxiang Yan, Dongmei Zhu, Xiaoping Hao, Lixin Zhu, Shuangli Ma, Qianli Liu, Jiajie Ma, Chao Nan, Lei Chen, Yong Ma, Xiaozhen Chen, Na Deng, Kun Shao, Ge Ding, Xianxiang An, Zhijie Rodewald, Lance E. Li, Xiaolei Wang, Dongyan Zhu, Hui Wang, Huaqing Feng, Zijian Xu, Wenbo Zhou, Jiushun Yin, Zundong JAMA Netw Open Original Investigation IMPORTANCE: The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations. OBJECTIVE: To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak. DESIGN, SETTING, AND PARTICIPANTS: This case series was conducted in China after a VDPV2 was detected in stool specimens from a child with acute flaccid paralysis (AFP) in Sichuan Province in 2019, 3 years after the global withdrawal of live, attenuated type 2 oral poliovirus vaccine (OPV). Investigation followed National Health Commission and World Health Organization guidance and included searching hospitals for unreported AFP cases; testing stool specimens from the child, his contacts, and local children; enhanced environmental surveillance for VDPV2s in wastewater; and measuring vaccination coverage. Sabin-strain IPV campaigns were conducted in a wide geographic area. MAIN OUTCOMES AND MEASURES: Any VDPV2 detection after completion of the supplementary immunization activities. RESULTS: A 28-nucleotide-change VDPV2 was isolated from a young boy. Three VDPV2s were detected in healthy children; 2 were contacts of the original child, and none had paralysis. A search of 31 million hospital records found 10 unreported AFP cases; none were polio. No type 2 polioviruses were found in wastewater. Prior to the event, polio vaccine coverage was 65% among children younger than 5 years. Sabin-strain IPV campaigns reached more than 97% of targeted children, administering 1.4 million doses. No transmission source was identified. More than 1 year of enhanced poliovirus environmental and AFP surveillance detected no additional VDPVs. CONCLUSIONS AND RELEVANCE: These findings suggest that the circulating VPDV2 outbreak in 2019 was associated with low vaccine coverage. An investigation discovered 3 infected but otherwise healthy children and no evidence of the virus in wastewater. Following Sabin-strain IPV–only campaigns expanding from county to prefecture, the poliovirus was not detected, and the outbreak response was considered by an expert panel and the World Health Organization to have been successful. This success suggests that the Sabin-strain IPV may be a useful tool for responding to circulating VDPV2 outbreaks when high-quality supplementary immunization activities can be conducted and carefully monitored in settings with good sanitation. American Medical Association 2023-01-05 /pmc/articles/PMC9856606/ /pubmed/36602797 http://dx.doi.org/10.1001/jamanetworkopen.2022.49710 Text en Copyright 2023 Yang H et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Yang, Hong Qi, Qi Zhang, Yong Wen, Ning Cao, Lei Liu, Yu Fan, Chunxiang Yan, Dongmei Zhu, Xiaoping Hao, Lixin Zhu, Shuangli Ma, Qianli Liu, Jiajie Ma, Chao Nan, Lei Chen, Yong Ma, Xiaozhen Chen, Na Deng, Kun Shao, Ge Ding, Xianxiang An, Zhijie Rodewald, Lance E. Li, Xiaolei Wang, Dongyan Zhu, Hui Wang, Huaqing Feng, Zijian Xu, Wenbo Zhou, Jiushun Yin, Zundong Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021 |
title | Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021 |
title_full | Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021 |
title_fullStr | Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021 |
title_full_unstemmed | Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021 |
title_short | Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021 |
title_sort | analysis of a sabin-strain inactivated poliovirus vaccine response to a circulating type 2 vaccine-derived poliovirus event in sichuan province, china 2019-2021 |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856606/ https://www.ncbi.nlm.nih.gov/pubmed/36602797 http://dx.doi.org/10.1001/jamanetworkopen.2022.49710 |
work_keys_str_mv | AT yanghong analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT qiqi analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT zhangyong analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT wenning analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT caolei analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT liuyu analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT fanchunxiang analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT yandongmei analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT zhuxiaoping analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT haolixin analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT zhushuangli analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT maqianli analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT liujiajie analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT machao analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT nanlei analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT chenyong analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT maxiaozhen analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT chenna analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT dengkun analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT shaoge analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT dingxianxiang analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT anzhijie analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT rodewaldlancee analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT lixiaolei analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT wangdongyan analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT zhuhui analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT wanghuaqing analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT fengzijian analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT xuwenbo analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT zhoujiushun analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 AT yinzundong analysisofasabinstraininactivatedpoliovirusvaccineresponsetoacirculatingtype2vaccinederivedpolioviruseventinsichuanprovincechina20192021 |